Eureka Therapeutics, Inc.

Insider Reports History

Entity
Company
Location
5858 Horton St Ste 170, Emeryville, California
Signature
/s/ Emily Semon, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eureka Therapeutics, Inc.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Estrella Immunopharma, Inc. 10%+ Owner Common Stock 25.3M Sep 29, 2023 Direct

Insider Reports Filed by Eureka Therapeutics, Inc.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
UPTD Estrella Immunopharma, Inc. Sep 29, 2023 0 $0 3 Oct 10, 2023 10%+ Owner